This report titled "The pharmaceuticals industry in Japan: current trends and emerging business opportunities for EU-based small- and medium-sized enterprises" is designed to inform EU SMEs about the evolving structure and development trajectory of the pharmaceuticals industry in Japan. It provides detailed information concerning the business environment of the pharmaceuticals industry, notably through different aspects such as political, legal, and technical factors. In addition, this report discusses the major barriers to market entry and proposes concrete recommendations through the expertise of professionals in the Japanese pharmaceuticals industry. Finally, it presents relevant case studies of EU SMEs having succeeded in entering the Japanese pharmaceuticals market.
About the Expert:
Dr. Keith Jackson is tutor and researcher at SOAS, University of London, and professor of Human Resource Management at Doshisha University, Kyoto. Dr. Jackson has over thirty years of experience working as a manager and talent management consultant for companies in many countries including Japan. In addition, Dr. Jackson designs in-company programmes for organisational learning and talent management for both for-profit and not-for-profit organisations. Click here to access his profile page.
The recording of the past webinar covering this topic is available for online viewers here. (Once you are logged in, look for the link below the "After event information")
Picture: Japanse drugstore
Copyright: EU-Japan Centre's private archives
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026